<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Sensitivity analysis in an Immuno-Epidemiological Vector-Host Model - Health AI Hub</title>
    <meta name="description" content="This paper introduces a novel immuno-epidemiological vector-host model that integrates within-host virus-immune system interactions with population-level diseas">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Sensitivity analysis in an Immuno-Epidemiological Vector-Host Model</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2111.11386v1" target="_blank">2111.11386v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2021-11-22
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Hayriye Gulbudak, Zhuolin Qu, Fabio Milner, Necibe Tuncer
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.PE, q-bio.QM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.90 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2111.11386v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="None" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a novel immuno-epidemiological vector-host model that integrates within-host virus-immune system interactions with population-level disease dynamics. By applying Sensitivity Analysis to this multi-scale model, the study quantifies the significant impact of immunological parameters, such as within-host pathogen growth rate, on epidemiological outcomes like R0 and host infectiousness. The findings underscore the potential importance of control strategies targeting within-host pathogen reduction for mitigating disease prevalence.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for medicine and public health as it provides a mechanistic link between individual immunological processes and population-wide disease spread, offering a more comprehensive framework for understanding and predicting epidemic dynamics. This integrated approach can directly inform the development and evaluation of novel drugs, vaccines, and other disease control strategies by identifying key immunological targets.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>Not explicitly mentioned in the abstract. The paper uses mathematical modeling (ODE system, sensitivity analysis) but does not describe the use of AI or machine learning methods in its approach.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Traditional Sensitivity Analysis (SA) in epidemiology has typically overlooked the influence of within-host virus-immune system dynamics on disease spread.</li>
                    
                    <li>The study develops an age-since-infection structured vector-host model where epidemiological parameters are dynamically linked to within-host virus and antibody densities, governed by an ODE system, bridging individual and population scales.</li>
                    
                    <li>SA is applied to this novel immuno-epidemiological model to assess how changes in immunological parameters affect population-level disease quantities (e.g., basic reproduction number (R0), final epidemic size, host infectiousness).</li>
                    
                    <li>Rift Valley Fever Disease (RVFD) is used as a case study, utilizing existing parameter estimations.</li>
                    
                    <li>Quantitative results for RVFD demonstrate that a 1% increase in the within-host pathogen growth rate can lead to substantial increases in population-scale disease metrics.</li>
                    
                    <li>Specifically, this 1% increase can result in up to an 8% increase in R0, up to a 1% increase in steady-state infected host abundance, and up to a 4% increase in host infectiousness when R0 is greater than one.</li>
                    
                    <li>The significant impact of within-host dynamics on population-level disease suggests that interventions targeting within-host pathogen growth could be crucial for effective disease control.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employs an age-since-infection structured vector-host model, which integrates within-host dynamics. Epidemiological parameters within this model are formulated as functions of within-host virus and antibody densities, governed by a system of Ordinary Differential Equations (ODEs). Sensitivity Analysis (SA) is then applied to this integrated immuno-epidemiological model to quantify the impact of specific immunological parameters on population-level disease outcomes.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The sensitivity analysis, using Rift Valley Fever Disease as a case study, revealed significant impacts of within-host immunological parameters on population-level disease metrics. A 1% increase in the within-host pathogen growth rate was found to lead to an up to 8% increase in the basic reproduction number (R0), an up to 1% increase in the steady-state abundance of infected hosts, and an up to 4% increase in the infectiousness of hosts when R0 exceeds one.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The findings have direct clinical and public health implications, suggesting that interventions aimed at reducing the within-host pathogen growth rate, such as antiviral therapies or vaccines that modulate immune responses, can play a critical role in decreasing population-level disease prevalence and controlling outbreaks. This highlights the importance of developing and deploying strategies that target host-pathogen interactions at the individual level to achieve broader public health benefits.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not explicitly mentioned in the abstract.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Not explicitly detailed in the abstract beyond the general utility for informing drug and vaccine development by connecting individual and population scales. The findings strongly imply a direction towards developing and evaluating control strategies specifically targeting within-host pathogen growth to reduce disease prevalence.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Infectious Diseases</span>
                    
                    <span class="tag">Epidemiology</span>
                    
                    <span class="tag">Immunology</span>
                    
                    <span class="tag">Virology</span>
                    
                    <span class="tag">Public Health</span>
                    
                    <span class="tag">Vaccine Development</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Sensitivity Analysis</span>
                    
                    <span class="tag tag-keyword">Immuno-Epidemiological Model</span>
                    
                    <span class="tag tag-keyword">Vector-Host Model</span>
                    
                    <span class="tag tag-keyword">Within-host Dynamics</span>
                    
                    <span class="tag tag-keyword">Rift Valley Fever</span>
                    
                    <span class="tag tag-keyword">Basic Reproduction Number (R0)</span>
                    
                    <span class="tag tag-keyword">Disease Control Strategies</span>
                    
                    <span class="tag tag-keyword">Multi-scale Modeling</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Sensitivity Analysis (SA) is a useful tool to measure the impact of changes in model parameters on the infection dynamics, particularly to quantify the expected efficacy of disease control strategies. SA has only been applied to epidemic models at the population level, ignoring the effect of within-host virus-with-immune-system interactions on the disease spread. Connecting the scales from individual to population can help inform drug and vaccine development. Thus the value of understanding the impact of immunological parameters on epidemiological quantities. Here we consider an age-since-infection structured vector-host model, in which epidemiological parameters are formulated as functions of within-host virus and antibody densities, governed by an ODE system. We then use SA for these immuno-epidemiological models to investigate the impact of immunological parameters on population-level disease dynamics such as basic reproduction number, final size of the epidemic or the infectiousness at different phases of an outbreak. As a case study, we consider Rift Valley Fever Disease (RFVD) utilizing parameter estimations from prior studies. SA indicates that 1% increase in within-host pathogen growth rate can lead up to 8% increase in R0; up to 1% increase in steady-state infected host abundance, and up to 4% increase in infectiousness of hosts when the reproduction number R0 is larger than one. These significant increases in population-scale disease quantities suggest that control strategies that reduce the within-host pathogen growth can be important in reducing disease prevalence.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>